Literature DB >> 23100870

Lipid abnormalities in chronic renal failure.

R Bhagwat1, S P Joshi, P Salgia, A Sepaha.   

Abstract

Lipid abnormalities remain to be a major cause of early mortality in patients with chronic renal failure (CRF). In present study, 114 (one hundred fourteen) CRF patients without any additional cause of dyslipidemia were divided into groups on the basis of etiologies of CRF. Blood samples from each group were analyzed for total cholesterol, triglyceride and HDL cholesterol along with blood urea nitrogen and serum creatinine. 25 healthy individuals without any obvious disease were taken as control. Patients from all the groups showed a marked hypertriglyceridemia of 232 (SD±77) mg/dl (P<0.001) as compared to control. Levels of HDL cholesterol were found to be significantly low 20 (±11) mg/dl (p<0.001) in all the groups. LDL cholesterol showed an increase 104 (±30) mg/dl as compared to control group which is not statistically significant. Present study reveals that, CRF patients show an uniform dyslipidemia irrespective of etiologies leading to CRF. This dyslipidemia is also independent of serum creatinine levels. Although, these lipid abnormalities may not solely cause mortality in CRF patients, they may act as modulators in accelerating atherogenesis which in turn cause early mortality in CRF patients.

Entities:  

Keywords:  Atherogenesis; Chronic Renal Failure (CRF); Dyslipidemia; High Density Lipids (HDL); Low Desity Lipids (LDL)

Year:  1997        PMID: 23100870      PMCID: PMC3454047          DOI: 10.1007/BF02867962

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  Renal injury of diet-induced hypercholesterolemia in rats.

Authors:  B L Kasiske; M P O'Donnell; P G Schmitz; Y Kim; W F Keane
Journal:  Kidney Int       Date:  1990-03       Impact factor: 10.612

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Should hyperlipemia of renal failure be treated?

Authors:  E Ritz; J Augustin; J Bommer; A Gnasso; W Haberbosch
Journal:  Kidney Int Suppl       Date:  1985-12       Impact factor: 10.545

4.  Hypertriglyceridemia. A metabolic consequence of chronic renal failure.

Authors:  J D Bagdade; D Porte; E L Bierman
Journal:  N Engl J Med       Date:  1968-07-25       Impact factor: 91.245

5.  Lipoprotein heterogeneity in end-stage renal disease.

Authors:  J Joven; E Vilella; S Ahmad; M C Cheung; J D Brunzell
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

Review 6.  Lipid abnormalities in uremia, dialysis, and transplantation.

Authors:  M K Chan; Z Varghese; J F Moorhead
Journal:  Kidney Int       Date:  1981-05       Impact factor: 10.612

7.  Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.

Authors:  M Sentí; R Romero; J Pedro-Botet; A Pelegrí; X Nogués; J Rubiés-Prat
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

8.  Relationship between vascular disease and age-associated changes in the human kidney.

Authors:  B L Kasiske
Journal:  Kidney Int       Date:  1987-05       Impact factor: 10.612

9.  Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.

Authors:  S L Jones; C F Close; M B Mattock; R J Jarrett; H Keen; G C Viberti
Journal:  BMJ       Date:  1989-02-25
  9 in total
  3 in total

1.  Lipid abnormalities, lipoprotein (a) and apoprotein pattern in non-dialyzed patients with chronic kidney disease.

Authors:  A Madhusudhana Rao; A R Bitla; E P Reddy; V Sivakumar; P V L N Srinivasa Rao
Journal:  Indian J Clin Biochem       Date:  2010-02-10

2.  Early oxidative change in low density lipoproteins during progressive chronic renal failure.

Authors:  M Sasikala; C Subramanyam; B Sadasivudu
Journal:  Indian J Clin Biochem       Date:  1999-07

3.  Dynamic changes of early-stage aortic lipid deposition in chronic renal failure rats and effects of decorin gene therapy.

Authors:  Hong-Bo Ma; Rong Wang; Ke-Zhou Yu; Che Yu
Journal:  Exp Ther Med       Date:  2014-12-04       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.